ASNS and small cell lung carcinoma: Recent large-scale analyses have established asparagine synthetase (ASNS) not only as a metabolic enzyme but a core driver of tumorigenic plasticity and metastatic progression across multiple cancer types, including SCLC, breast, and colorectal cancer.